Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Gabriella Pellegriti

Researcher , Medical Oncology

University of Catania

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (14)

Marco Miniotti

Research Fellow, Assistant Professor

Università degli Studi di Torino

ITALY

View details

simone de leo

Istituto Auxologico Italiano

ITALY

View details

Maria Plana

Institut Català d'Oncologia

SPAIN

View details

H M van Santen

Associate Group Leader , pediatric endocrinologist

Princess Maxima Center

NETHERLANDS

View details

Pablo Valderrabano

H Lee Moffitt Cancer Center and Research Institute

UNITED STATES

View details

Montserrat Negre Busó

Specialist

Institut de Diagnòstic per la Imatge

SPAIN

View details

tiago nunes da silva

Portuguese Oncology Institute

PORTUGAL

View details

Giorgio Grani

Associate Professor of Internal Medicine

Sapienza University of Rome

ITALY

View details

Anton F Engelsman

VU medisch centrum

NETHERLANDS

View details

jonathan wadsley

University of Sheffield

UNITED KINGDOM

View details

Antonino BELFIORE

Professor of Endocrinology

University of Catania

ITALY

View details

Livia Lamartina

Head of Endocrine Oncology Unit

Institut Gustave Roussy

FRANCE

View details

Giuseppe Fanetti

Professore a Contratto

University of Padua

ITALY

View details

Ellen H. W. Kapiteijn

Professor in Medical Oncology

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gabriella Pellegriti

Research Interests

Make your next move.

Explore related searches

Articles (17)

Determinants of Health-Related Quality of Life in Differentiated and Poorly Differentiated Thyroid Cancer Patients With Structural Incomplete Response: A Multicenter Cross-Sectional Study

The Thyroid Under Pressure: Heavy Metals, Endocrine Disruptors and Translational Insights into Carcinogenesis and Thyroid Dysfunctions

Comprehensive evaluation of TIR 3B thyroid nodules: Clinical, Ultrasonographical and Cytological features for prediction of malignancy

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

International Consensus on the Requirements for Definitions of Complete Remission and Recurrence of Differentiated Thyroid Cancer: a Delphi Study (ICON-DTC).

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)

Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center

Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer

Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study

Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age]

Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients

Phase 3 Trial of Selpercatinib in Advanced <i>RET</i> -Mutant Medullary Thyroid Cancer

Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol

Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes

Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato

Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM

Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review

Collaborators (14)

Marco Miniotti

simone de leo

Maria Plana

H M van Santen

Pablo Valderrabano

Montserrat Negre Busó

tiago nunes da silva

Giorgio Grani

Anton F Engelsman

jonathan wadsley

Antonino BELFIORE

Livia Lamartina

Giuseppe Fanetti

Ellen H. W. Kapiteijn

Make your next move.